Clinical Trial

Impact of Protect Your Colon™ on CRC Screening

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.
Protocol Amendment History 1 change
critical Enrollment closed, study ongoing 2026-08-08
Trial Details
NCT Number NCT05929820
Lead Sponsor Cedars-Sinai Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Colorectal Cancer Screening
Enrollment 184 participants
Start Date 2023-09-28
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07